Skip to Content

Vetera 4XP + WNV

This page contains information on Vetera 4XP + WNV for veterinary use.
The information provided typically includes the following:
  • Vetera 4XP + WNV Indications
  • Warnings and cautions for Vetera 4XP + WNV
  • Direction and dosage information for Vetera 4XP + WNV

Vetera 4XP + WNV

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Encephalomyelitis-Influenza-West Nile Virus Vaccine,

Eastern & Western, Killed Virus

Tetanus Toxoid

Vetera 4XP + WNV Indications

For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03. The duration of immunity against West Nile Virus is at least 12 months.

Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure

with a single 1 mL intramuscular dose.

Precautions

Store at 35-45°F (2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Preservatives: Gentamicin and Amphotericin B.

For Veterinary Use Only

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GMBH.

© 2013 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

US Vet. Lic. No. 124

 

Code

 

1 Dose/1 mL

137-815

137804-03

10 Doses/10 mL

137-825

137803-03

NAC No.: 1028271.1

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.biviultraduramune.com
    www.bividollarsandsense.com
    www.bronchi-shieldoral.com
    www.duramunelepto.com
    www.duramunelyme.com
    www.haveweseenyourcatlately.com
    www.metacam.com
    www.mycathasdiabetes.com
    www.productionvalues.us
    www.prrsresearch.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Vetera 4XP + WNV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide